<?xml version="1.0" encoding="UTF-8"?>
<p id="Par74">Bocavirus (hBoV) has been associated with 2â€“19% of all URTI and LRTI worldwide. The virus has also been found in patients with hematological malignancies or HSCT; however, it is difficult to establish its real impact in terms of morbidity and mortality because of the high frequency of co-infections [
 <xref ref-type="bibr" rid="CR2">2</xref>]; estimated incidence ranges between 1 and 3% [
 <xref ref-type="bibr" rid="CR6">6</xref>]. A prospective study carried out on children diagnosed with cancer showed that hBoV was present in 8% of viral respiratory infections and in 19% of LRTI. In the latter, 57% of cases were related to a co-infection with other viruses [
 <xref ref-type="bibr" rid="CR14">14</xref>].
</p>
